Ajanta Selling And Marketing Expenses from 2010 to 2025
| AJANTPHARM | 2,560 64.65 2.59% |
Selling And Marketing Expenses | First Reported 2010-12-31 | Previous Quarter 2.9 B | Current Value 2 B | Quarterly Volatility 721.6 M |
Check Ajanta Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ajanta Pharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.6 B, Interest Expense of 83.5 M or Selling And Marketing Expenses of 2 B, as well as many indicators such as . Ajanta financial statements analysis is a perfect complement when working with Ajanta Pharma Valuation or Volatility modules.
Ajanta | Selling And Marketing Expenses |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ajanta Stock
Ajanta Pharma financial ratios help investors to determine whether Ajanta Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ajanta with respect to the benefits of owning Ajanta Pharma security.